FMP

FMP

Blogs by Gordon Thompson

blog post title

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives $17 Price Target from Chardan Capital

On October 7, 2025, Chardan Capital set a price target of $17 for Lexeo Therapeutics, Inc. (NASDAQ:LXEO). At the time, the stock was trading at $8.25, suggesting a potential increase of about 94%. Lex...

blog post title

Significant Movements in the Stock Market: Top Gainers Across Various Sectors

In a remarkable turn of events, the stock market has seen significant movements among its top gainers, with companies ac...

blog post title

McCormick & Company, Inc. (NYSE:MKC) Surpasses Earnings Estimates

McCormick & Company, Inc. (NYSE:MKC) is a global leader in the flavor industry, known for its premium spices and seasoni...

blog post title

JPMorgan Chase & Co. (NYSE:JPM) Earnings Preview and Financial Analysis

JPMorgan Chase & Co. (NYSE:JPM) is a leading global financial institution, known for its comprehensive range of services...

blog post title

Jefferies Upgrades Advanced Micro Devices (NASDAQ:AMD) to "Positive"

On October 6, 2025, Jefferies upgraded Advanced Micro Devices (NASDAQ:AMD) to a "Positive" rating. This decision was inf...

blog post title

Constellation Brands Inc (NYSE: STZ) Surpasses Earnings Expectations

Constellation Brands Inc (NYSE: STZ), a key player in the Beverages - Alcohol industry, recently reported its fiscal sec...

blog post title

Embraer S.A. (NYSE: ERJ) Sees Positive Financial and Market Movements

Embraer S.A. (NYSE: ERJ) is a prominent Brazilian aerospace company known for manufacturing commercial, military, execut...

blog post title

Impact of Craig-Hallum Downgrade on Skye Bioscience (SKYE) Stock

Skye Bioscience, trading under the symbol SKYE on the NASDAQ, is a company involved in the development of pharmaceutical...

blog post title

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Overview: A Deep Dive into Financials and Developments

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is a prominent player in the field of RNA interference (RNAi) therapeutics. ...

blog post title

Quantum Computing Inc. (NASDAQ:QUBT) Sees Significant Price Target Increase from Ascendiant

Quantum Computing Inc. (NASDAQ:QUBT) is a company focused on developing quantum computing solutions. It aims to harness ...